Use of cytokines and mitogens to inhibit graft versus host disease
US7799350B2 · kind B2 · utility
0Cited by
6References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 16, 2007 |
| Grant date | Sep 21, 2010 |
| Priority date | — |
| Expiry date | Oct 16, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for inducing T cell tolerance in peripheral blood mononuclear cells (PBMCs) comprising adding a suppressive composition to said cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.